Inflammatory Mediators in Erythema Migrans

Status Completed

Clinical Trial Summary

The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03956212
Study type	Interventional
Source	University Medical Centre Ljubljana
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2017
Completion date	October 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01368341` - Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice	Phase 4
Completed	`NCT01518192` - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome	Phase 4
Recruiting	`NCT03966014` - Different Amoxicillin Treatment Regimens in Erythema Migrans Patients	N/A
Recruiting	`NCT03462329` - Patient's Pretreatment Expectations About Post-Lyme Symptoms	N/A
Completed	`NCT03980015` - Inflammatory Responses in Solitary and Multiple Erythema Migrans
Completed	`NCT03505879` - Next Generation Sequencing Detection of Lyme Disease
Recruiting	`NCT02147249` - Cytokines and Chemokines in Erythema Migrans	N/A
Completed	`NCT02145754` - Culture Media for Borrelia Burgdorferi Sensu Lato	N/A
Completed	`NCT03371563` - Erythema Migrans in Elderly
Completed	`NCT02414789` - Lyme Borreliosis and Early Cutaneous Diagnostic	N/A
Completed	`NCT00132327` - Analysis of Lyme Disease Lesions